FDA Approved: XIIDRA — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved XIIDRA (lifitegrast) via an original NDA for the treatment of dry eye disease. The product is manufactured by Novartis Pharmaceuticals Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Xiidra (Lifitegrast)

Snippet

ORIG AP for XIIDRA (LIFITEGRAST)